Dr. Larry Einhorn - Platinum Anniversary Celebration https://t.co/1FsgLFR2c8 via @YouTube
Been at IU for nearly 20 years and this video from the 1st testicular cancer patient to receive the PVB platinum-based regimen still gets me every time!! Revolutionary stuff!!! @04:29
So proud and honored to see our latest work on Prostate Health Index (PHI) in AAM in the May issue @urogoldjournal with cover & tribute to our dear friend and colleague Dr Alan Partin. So fitting but so sad to have lost him so young! @ThomasPolascik@Kost_Morr@DrKotamarti
Kudos to @Kost_Morr@IUuro for great job on our latest work on secondary prostate cancer screening test PHI in AAM @DukeUrology @DukeUroRes@DukeGUCancer https://t.co/UQ6GtUEo3t
Judd W. Moul, MD, spoke with CancerNetwork® about the latest research from the journal ONCOLOGY® on the treatment of a patients with evidence of prostate cancer despite multiple negative prognostic tests. #pcsm | @JuddMoul@Kost_Morr
https://t.co/HMTmukidnb
@AmerUrological#AUA22 first podium for @Kost_Morr who did a stellar job with our PHI database and survived questions from moderator Dr Catalona who discovered PHI- is that pressure or what! Great session!
Today on Second Opinion: @JuddMoul discusses with @Kost_Morr the case of a patient who presented with elevated prostate-specific antigen levels & multiple imaging tests that appeared to indicate an absence of malignancy. @CancerNetwrk@byMattHoffman
https://t.co/NrxfVfDVs3
Dr. Judd W. Moul, MD, and colleagues present the case of a man, aged 73 years, with a prostate-specific antigen level of 110 ng/mL after 4 negative prostate biopsies and 4 negative prostate MRIs. #pcsm | @JuddMoul@Kost_Morr
https://t.co/bBD6H2kk5l
We could not be more excited to match Ginnie, Kostantinos, Will, and Leo to our program! Congratulations to these future IU Urologists. Sunglasses to come because the future is bright! #AUAMatch#uromatch@AmerUrological
Congrats to my @DukeMedSchool colleague @Kost_Morr for matching at @UrologyofIN urology. But, I told him not to let it go to his head because we still have papers to write! Today though is all about celebrating our new future urologists! @DukeUrology @DukeUroRes
Kudos to @Kost_Morr@DrKotamarti for strong work in having a number of abstracts accepted for #AUA22 related to our work in prostate cancer early detection! We also have an EAU-Amsterdam presentation accepted but concerned about attending in person due to #Omikron surge
A research collaboration between scientists at @Duke and @UNC has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19. https://t.co/rz3anvvL3J @TheDHVI
This study aimed to compare the same regimens in individuals at moderate to high risk for sepsis undergoing percutaneous nephrolithotomy. https://t.co/HjiqhvrC7m
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance—Does Magnetic Resonance Imaging Have a Role? https://t.co/WOlOaJo22o
AUA Guideline Part I: Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia -- Initial Work-up and Medical Management
https://t.co/BVfFmKe3Sm